| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 337 / 428 | 21st | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
China Oncology
China Oncology is Scopus-indexed (Q4, CiteScore 1), DOAJ. Published by Editorial Office of China Oncology.
Checked against the index lists dated .
ISSN 1007-3639Verify ISSN ↗
Publisher: Editorial Office of China Oncology
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is China Oncology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 1.
What quartile is China Oncology in Scopus?
China Oncology is Q4 in Oncology (rank 337 of 428), by CiteScore 2025.
What is the impact factor of China Oncology?
China Oncology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1, quartile Q4, 21st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.185, quartile Q4, with an H-index of 10.
How much does it cost to publish in China Oncology?
The publisher lists an article processing charge of about US$726 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes China Oncology and what is its ISSN?
China Oncology is published by Editorial Office of China Oncology. Its ISSN is 1007-3639.
Is China Oncology in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is China Oncology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is China Oncology? — open metrics via OpenAlex
China Oncology has an h-index of 7 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q4. On 2-year citations it ranks #402 of 424 Scopus journals in Oncology.
China Oncology published 10 papers in 2021; its busiest recent year was 2016 with 201. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for China Oncology? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.